InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Thursday, 06/01/2017 1:45:13 PM

Thursday, June 01, 2017 1:45:13 PM

Post# of 2099
Comparison to celldex and avastin.
2016 video but in case anyone missed it:


Unlike celldex
- No patient selection
- Took the most severe cases

Compare to avastin
- Based on response rate
- Failed to show increase in survival and pfs
- After failure: avastin patients live only a few months (cliff); with VB-111 patients live for almost a year (tumor grow at slower pace compared to avastin only)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News